Hong Kong's rush into raising healthcare charges is a mistake
[email protected] or filling in
this Google form . Submissions should not exceed 400 words, and must include your full name and address, plus a phone number for verification
Advertisement
Hong Kong's public healthcare system was built on a promise: no one should be bankrupted by illness. With the government eyeing substantial
fee increases for emergency and diagnostic services, we're left wondering if officials have thought this through. Against a backdrop of an
ageing population , younger individuals developing chronic conditions and spiralling medical costs, the proposal is poorly timed. Raising fees without a comprehensive
financing plan is like rearranging deck chairs on the Titanic – it misses the iceberg entirely.
The current system, where the government foots
97 per cent of public healthcare costs, has papered over three glaring structural problems. First, we're facing a severe public-private resource imbalance. Private hospitals enjoy tax breaks and
discounted land grants while charging fees that make most citizens recoil. When emergency services costing HK$2,400 (US$310) are
priced at just HK$180 , is it any surprise patients with minor sniffles flock to public facilities?
Second, the
voluntary insurance scheme has turned out to be a damp squib. Without provisions for
high-risk pooling or guaranteed acceptance, chronic patients and vulnerable groups have been left high and dry. Third,
primary care – the frontline defence that could take pressure off hospitals – remains woefully underdeveloped.
Without tackling these issues head-on, fee increases will hit vulnerable groups hard. Middle-class families already struggle with expenses for cancer medications that cost up to HK$20,000 per month. Working-class residents might delay treatment until their condition worsens, while chronic patients might skip vital check-ups altogether.
Advertisement
The government should implement three substantial solutions instead of rushing towards fee increases.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
20 hours ago
- South China Morning Post
US begins organ-transplant reform as ‘signs of life' found before some retrievals
The US Department of Health and Human Services (HHS) has launched a reform of the organ-transplant system and threatened to close a major procurement body after a probe found premature attempts to start organ retrieval while patients showed signs of life. The investigation conducted by the Health Resources and Services Administration (HRSA), a division of HHS, examined 351 cases where organ donation was authorised but not completed. It found 73 patients had shown neurological signs incompatible with organ donation and at least 28 patients may not have been deceased at the time organ procurement was initiated, the HHS said in a statement on Monday. The probe also found evidence of poor neurologic assessments, questionable consent practices, and misclassification of causes of death in several cases, the agency said.
HKFP
2 days ago
- HKFP
Hong Kong's Hospital Authority negotiates lower prices for medication as part of cost-cutting measures
Hong Kong's Hospital Authority has negotiated lower prices for medication following discussions with pharmaceutical firms, as part of cost-cutting measures aimed at optimising resources. Hospital Authority chief executive Tony Ko said on Wednesday that, of the pharmaceutical firms it had spoken with – most of which make drugs for cancer and chronic conditions – around 70 per cent agreed to lower prices. The average price cut was about 20 per cent. The Hospital Authority is also planning to rely more on generic drugs instead of brand-name medication, Ko said, citing expiring patents on some drugs paving the way for other manufacturers. William Chui, the Hospital Authority's chief pharmacist, said that market competition could lower prices across the board. 'Whether it's generic drugs manufactured in India, Western countries or mainland China, the original manufacturers will follow by reducing their prices,' Chui said in Cantonese. Last year, the Hospital Authority established a 'Cost Assessment Panel' to negotiate costs with pharmaceutical firms. In March, the Health Bureau said it had reduced procurement costs for some drugs for colon cancer and paroxysmal nocturnal haemoglobinuria, a type of rare blood disorder. The Hospital Authority will continue to promote the 'diversification of drug supply so as to provide patients with safe, efficacious and cost-effective drugs,' the bureau added. On Wednesday, Chui said authorities had taken reference from drug prices offered under mainland China's medical insurance system while negotiating costs. The Hospital Authority is also looking to purchase medical equipment from mainland China, he said. Ko added on Wednesday that the Hospital Authority has been using artificial intelligence (AI) to draft medical reports since March. Around 80 per cent of reports can be processed by AI, he said, helping save about 40 per cent of the time staff spend handling paperwork. Lowered drug costs at public hospitals come as the city is set to raise fees for services such as non-critical Accident and Emergency (A&E) room visits. The hike is part of a reform that Secretary for Health Lo Chung-mau called 'belated and necessary,' saying that the current public healthcare system, which is heavily subsidised by the government, is not sustainable. Under the new plan, patients classified as 'urgent,' 'semi-urgent,' or 'non-urgent' will have to pay HK$400 for A&E services. The current fee has been HK$180 since 2017. Patients classified as 'critical,' referring to those who should receive immediate medical attention and those classified as 'emergency,' which should be attended to within 15 minutes, will be treated for free.
RTHK
2 days ago
- RTHK
HA to slash costs by $1bn in efficiency drive
HA to slash costs by $1bn in efficiency drive HA Chief Executive Tony Ko (centre) says measures have been taken in various departments to compress costs and reduce staff workload. Photo: RTHK The Hospital Authority (HA) said a series of measures it has undertaken to streamline workflow and its procurement system could translate into savings of HK$1 billion, while patients would benefit through cheaper and a wider choice of medications. In a press briefing, the authority's chief pharmacist William Chui said a cost assessment panel set up to negotiate with pharmaceutical firms has paid dividends. 'We would negotiate the price based on scientific research and advice by medical economists,' he said, adding they would take reference from prices on the mainland. As a result, Chui revealed that seven out of 10 suppliers have agreed to lower drug prices, with an average reduction of 20 percent. HA Chief Executive Tony Ko, meanwhile, gave updates on the use of artificial intelligence tools to enhance efficiency and ease the workload of frontline staff. He pointed to a Smart Antibiotic Stewardship Programme which can automatically identify potentially inappropriate use of antibiotics through protocol-driven algorithm. Officially rolled out in January 2024, Ko said the tool saved time and effort as medics no longer had to comb through different databases to obtain patients' records. 'In the past, before we have this AI initiative, we need the expert colleagues, for example, our infectious disease expert or microbiology expert, to look into the various laboratory results to check the patient's conditions…before you decide whether you need to change antibiotics,' Ko said. 'We developed our own clinical management system for almost 30 years, and all the data are within our systems. Instead of asking people to do it manually, to check whether a certain patient still needed a certain broad-spectrum antibiotic, now it's all in the system and automated.' The HA has also been using automated tools to tackle the large number of medical and discharge reports, with around 100,000 such requests received annually. Ko said 80 percent of these reports can be generated by AI, reducing the time staff typically spent on this task by 40 percent, and their workload by one-third. Every report will be manually verified to ensure accuracy, he added, while complex cases still have to be handled entirely by physicians.
